New Zealand markets closed

iHuman Inc. (IH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
2.2000+0.2200 (+11.11%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 101.19M
Enterprise value -17.56M
Trailing P/E 7.89
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.74
Price/book (mrq)1.07
Enterprise value/revenue -0.02
Enterprise value/EBITDA 0.85

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-50.11%
S&P500 52-week change 3-16.62%
52-week high 35.4700
52-week low 31.1000
50-day moving average 32.0902
200-day moving average 32.4261

Share statistics

Avg vol (3-month) 35.83k
Avg vol (10-day) 33.55k
Shares outstanding 553.26M
Implied shares outstanding 6N/A
Float 816.46M
% held by insiders 113.08%
% held by institutions 114.31%
Shares short (14 Sept 2022) 447.97k
Short ratio (14 Sept 2022) 412.62
Short % of float (14 Sept 2022) 4N/A
Short % of shares outstanding (14 Sept 2022) 40.09%
Shares short (prior month 14 Aug 2022) 447.96k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin -1.15%
Operating margin (ttm)-2.12%

Management effectiveness

Return on assets (ttm)-1.13%
Return on equity (ttm)-1.69%

Income statement

Revenue (ttm)970.09M
Revenue per share (ttm)18.18
Quarterly revenue growth (yoy)4.20%
Gross profit (ttm)660.62M
EBITDA -12.32M
Net income avi to common (ttm)-11.2M
Diluted EPS (ttm)0.2800
Quarterly earnings growth (yoy)1,042.60%

Balance sheet

Total cash (mrq)856.33M
Total cash per share (mrq)16.08
Total debt (mrq)18.1M
Total debt/equity (mrq)2.71
Current ratio (mrq)2.27
Book value per share (mrq)12.55

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A